Authors: HENRY D ELLISON W SULLIVAN J MANSFIELD DL MAGNER DJ DORR MB TALBOT GH

Citation: D. Henry et al., TREATMENT OF COMMUNITY-ACQUIRED ACUTE UNCOMPLICATED URINARY-TRACT INFECTION WITH SPARFLOXACIN VERSUS OFLOXACIN, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2262-2266

Authors: ELIOPOULOS GM WENNERSTEN CB GOLD HS SCHULIN T SOULI M FARRIS MG CERWINKA S NADLER HL DOWZICKY M TALBOT GH MOELLERING RC

Citation: Gm. Eliopoulos et al., CHARACTERIZATION OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM ISOLATES FROM THE UNITED-STATES AND THEIR SUSCEPTIBILITY IN-VITRO TO DALFOPRISTIN-QUINUPRISTIN, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1088-1092

Authors: DEABATE CA HENRY D BENSCH G JUBRAN A CHODOSH S HARPER L TIPPING D TALBOT GH

Citation: Ca. Deabate et al., SPARFLOXACIN VS OFLOXACIN IN THE TREATMENT OF ACUTE BACTERIAL EXACERBATIONS OF CHRONIC-BRONCHITIS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, COMPARATIVE-STUDY, Chest, 114(1), 1998, pp. 120-130

Authors: DONOWITZ GR BRANDON ML SALISBURY JP HARMAN CP TIPPING DM URICK AE TALBOT GH

Citation: Gr. Donowitz et al., SPARFLOXACIN VERSUS CEFACLOR IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA - A RANDOMIZED, DOUBLE-MASKED, COMPARATIVE, MULTICENTER STUDY, Clinical therapeutics, 19(5), 1997, pp. 936-953

Authors: COHEN MA YODER SL TALBOT GH

Citation: Ma. Cohen et al., SPARFLOXACIN WORLDWIDE IN-VITRO LITERATURE - ISOLATE DATA AVAILABLE THROUGH 1994, Diagnostic microbiology and infectious disease, 25(2), 1996, pp. 53-64

Authors: PENTIKIS HS JOHNSON RD HUANG MY JENSEN BK HEALD DL DORR MB TALBOT GH

Citation: Hs. Pentikis et al., POPULATION PHARMACOKINETIC ANALYSIS OF SPARFLOXACIN PLASMA-CONCENTRATIONS OBTAINED IN PHASE-III CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 70-70